Rock Springs Capital Management as of March 31, 2025
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 96 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 6.0 | $104M | 176k | 591.87 | |
| Eli Lilly & Co. (LLY) | 5.4 | $94M | 114k | 825.91 | |
| Blueprint Medicines (BPMC) | 5.1 | $89M | 1.0M | 88.51 | |
| Madrigal Pharmaceuticals (MDGL) | 3.2 | $55M | 167k | 331.23 | |
| UnitedHealth (UNH) | 3.0 | $53M | 101k | 523.75 | |
| Travere Therapeutics (TVTX) | 3.0 | $52M | 2.9M | 17.92 | |
| Intuitive Surgical Com New (ISRG) | 2.9 | $51M | 102k | 495.27 | |
| Ultragenyx Pharmaceutical (RARE) | 2.9 | $51M | 1.4M | 36.21 | |
| Penumbra (PEN) | 2.6 | $46M | 171k | 267.41 | |
| Revolution Medicines (RVMD) | 2.6 | $45M | 1.3M | 35.36 | |
| Rhythm Pharmaceuticals (RYTM) | 2.5 | $44M | 834k | 52.97 | |
| Mirum Pharmaceuticals (MIRM) | 2.5 | $43M | 952k | 45.05 | |
| Merus N V (MRUS) | 2.4 | $41M | 981k | 42.09 | |
| Insmed Com Par $.01 (INSM) | 2.3 | $39M | 516k | 76.29 | |
| Alnylam Pharmaceuticals (ALNY) | 2.2 | $39M | 143k | 270.02 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.9 | $34M | 216k | 155.86 | |
| Zai Lab Adr (ZLAB) | 1.9 | $33M | 905k | 36.14 | |
| Xenon Pharmaceuticals (XENE) | 1.8 | $31M | 932k | 33.55 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $31M | 279k | 110.60 | |
| Nuvalent Inc-a (NUVL) | 1.7 | $30M | 428k | 70.92 | |
| Agilon Health (AGL) | 1.7 | $30M | 7.0M | 4.33 | |
| Phreesia (PHR) | 1.7 | $29M | 1.1M | 25.56 | |
| Boston Scientific Corporation (BSX) | 1.6 | $28M | 277k | 100.88 | |
| Akero Therapeutics (AKRO) | 1.6 | $27M | 673k | 40.48 | |
| Dex (DXCM) | 1.6 | $27M | 398k | 68.29 | |
| Irhythm Technologies (IRTC) | 1.5 | $27M | 254k | 104.68 | |
| Evolent Health Cl A (EVH) | 1.5 | $26M | 2.7M | 9.47 | |
| Scholar Rock Hldg Corp (SRRK) | 1.4 | $25M | 762k | 32.15 | |
| Kymera Therapeutics (KYMR) | 1.2 | $22M | 794k | 27.37 | |
| EXACT Sciences Corporation (EXAS) | 1.2 | $21M | 480k | 43.29 | |
| Acadia Healthcare (ACHC) | 1.2 | $21M | 681k | 30.32 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.1 | $20M | 1.1M | 17.31 | |
| Summit Therapeutics (SMMT) | 1.1 | $19M | 995k | 19.29 | |
| Edwards Lifesciences (EW) | 1.1 | $19M | 255k | 72.48 | |
| Tarsus Pharmaceuticals (TARS) | 1.0 | $18M | 354k | 51.37 | |
| Tenet Healthcare Corp Com New (THC) | 1.0 | $18M | 130k | 134.50 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.0 | $17M | 513k | 33.93 | |
| Immunovant (IMVT) | 1.0 | $17M | 976k | 17.09 | |
| Brooks Automation (AZTA) | 0.9 | $17M | 475k | 34.64 | |
| Inspire Med Sys (INSP) | 0.9 | $16M | 99k | 159.28 | |
| Amicus Therapeutics (FOLD) | 0.9 | $16M | 1.9M | 8.16 | |
| Warby Parker Cl A Com (WRBY) | 0.9 | $15M | 835k | 18.23 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.9 | $15M | 6.7M | 2.25 | |
| Celldex Therapeutics Com New (CLDX) | 0.8 | $15M | 813k | 18.15 | |
| Oscar Health Cl A (OSCR) | 0.8 | $14M | 1.1M | 13.11 | |
| West Pharmaceutical Services (WST) | 0.8 | $14M | 60k | 223.88 | |
| Vera Therapeutics Cl A (VERA) | 0.7 | $13M | 521k | 24.02 | |
| Danaher Corporation (DHR) | 0.7 | $12M | 59k | 205.00 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.6 | $11M | 536k | 20.47 | |
| Sarepta Therapeutics (SRPT) | 0.6 | $10M | 159k | 63.82 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $10M | 342k | 29.30 | |
| Pharvaris N V (PHVS) | 0.6 | $9.8M | 623k | 15.70 | |
| Compass Therapeutics (CMPX) | 0.5 | $9.4M | 5.0M | 1.90 | |
| Enliven Therapeutics (ELVN) | 0.5 | $9.2M | 466k | 19.68 | |
| Soleno Therapeutics (SLNO) | 0.5 | $8.9M | 124k | 71.45 | |
| Ardelyx (ARDX) | 0.5 | $7.9M | 1.6M | 4.91 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $7.7M | 5.0M | 1.53 | |
| Zenas Biopharma (ZBIO) | 0.4 | $6.9M | 879k | 7.90 | |
| 89bio (ETNB) | 0.4 | $6.1M | 844k | 7.27 | |
| Prothena Corp SHS (PRTA) | 0.3 | $6.1M | 493k | 12.38 | |
| Janux Therapeutics (JANX) | 0.3 | $5.5M | 205k | 27.00 | |
| Dyne Therapeutics (DYN) | 0.3 | $5.5M | 525k | 10.46 | |
| Gossamer Bio Note 5.000% 6/0 (Principal) | 0.3 | $5.3M | 9.6M | 0.55 | |
| Mineralys Therapeutics (MLYS) | 0.3 | $5.1M | 321k | 15.88 | |
| Cullinan Oncology (CGEM) | 0.3 | $4.9M | 645k | 7.57 | |
| Nevro (NVRO) | 0.3 | $4.7M | 801k | 5.84 | |
| Bicara Therapeutics (BCAX) | 0.3 | $4.4M | 336k | 13.03 | |
| Novavax Com New (NVAX) | 0.2 | $4.2M | 650k | 6.41 | |
| Kestra Med Technologies SHS (KMTS) | 0.2 | $3.6M | 145k | 24.92 | |
| Gossamer Bio (GOSS) | 0.2 | $3.6M | 3.3M | 1.10 | |
| Pulmonx Corp (LUNG) | 0.2 | $3.4M | 504k | 6.73 | |
| Inozyme Pharma (INZY) | 0.2 | $3.1M | 3.4M | 0.91 | |
| Beam Therapeutics (BEAM) | 0.2 | $2.9M | 150k | 19.53 | |
| Alphatec Hldgs Com New (ATEC) | 0.2 | $2.7M | 268k | 10.14 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $2.6M | 788k | 3.26 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.1 | $2.5M | 1.3M | 1.96 | |
| Jasper Therapeutics Com New (JSPR) | 0.1 | $2.3M | 545k | 4.30 | |
| Lenz Therapeutics (LENZ) | 0.1 | $2.1M | 83k | 25.71 | |
| Regeneron Pharmaceuticals (REGN) | 0.1 | $1.8M | 2.8k | 634.23 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $1.7M | 80k | 21.87 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.7M | 222k | 7.50 | |
| Macrogenics (MGNX) | 0.1 | $1.5M | 1.1M | 1.27 | |
| Compugen Ord (CGEN) | 0.1 | $1.4M | 990k | 1.46 | |
| Mersana Therapeutics | 0.1 | $1.3M | 3.8M | 0.34 | |
| Neurogene (NGNE) | 0.1 | $1.2M | 104k | 11.71 | |
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $1.2M | 343k | 3.54 | |
| Sionna Therapeutics (SION) | 0.1 | $1.0M | 99k | 10.46 | |
| Applied Therapeutics (APLT) | 0.1 | $1.0M | 2.1M | 0.49 | |
| Perspective Therapeutics Com New (CATX) | 0.1 | $947k | 444k | 2.13 | |
| Vigil Neuroscience (VIGL) | 0.0 | $840k | 472k | 1.78 | |
| Pliant Therapeutics (PLRX) | 0.0 | $797k | 590k | 1.35 | |
| Spruce Biosciences (SPRB) | 0.0 | $757k | 2.6M | 0.29 | |
| Korro Bio (KRRO) | 0.0 | $622k | 36k | 17.41 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.0 | $489k | 2.5M | 0.20 | |
| Talphera Com New (TLPH) | 0.0 | $157k | 317k | 0.49 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $32k | 134k | 0.24 |